Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tayfur Toptas

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Hematology|April 3, 2015
Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literatureBulent Kantarcioglu, Isik Kaygusuz-Atagunduz, Ant Uzay, et al.
Blood Research|December 17, 2021
Real-life ruxolitinib experience in intermediate-risk myelofibrosisFatma Arikan, Tayfur Toptas, Isik Kaygusuz Atagunduz, et al.
Histopathology|July 25, 2013
Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemiaM Hilmi Atay, Duzgun Ozatli, Engin Kelkitli, et al.
Biomarkers in Medicine|April 22, 2010
Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?Billur Canbakan, Hakan Senturk, Mustafa Canbakan, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2016
Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's diseaseFatma Alibaz-Oner, Belgin Aldag, Mustafa Aldag, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 22, 2020
Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid LeukemiaHayri Bostan, Tayfur Toptas, Funda Pepedil Tanrikulu, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 24, 2022
Splenectomy in İmmune Thrombocytopenia: A Retrospective Analysis of 25-Year Follow-up Data from a Tertiary Health ClinicSerdar Ozkok, Isik Kaygusuz Atagunduz, Osman Kara, et al.
Current Problems in Cancer|May 15, 2025
Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literatureOzlem Candan, Derya Demirtas, Fatma Temiz, et al.
Nephron. Clinical Practice|September 18, 2010
Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis CMustafa Canbakan, Hakan Senturk, Billur Canbakan, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2017
Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib MesylateIsik Kaygusuz Atagunduz, Tayfur Toptas, Rabia Deniz, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Hematology|April 3, 2015
Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literatureBulent Kantarcioglu, Isik Kaygusuz-Atagunduz, Ant Uzay, et al.
Blood Research|December 17, 2021
Real-life ruxolitinib experience in intermediate-risk myelofibrosisFatma Arikan, Tayfur Toptas, Isik Kaygusuz Atagunduz, et al.
Histopathology|July 25, 2013
Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemiaM Hilmi Atay, Duzgun Ozatli, Engin Kelkitli, et al.
Biomarkers in Medicine|April 22, 2010
Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?Billur Canbakan, Hakan Senturk, Mustafa Canbakan, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2016
Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's diseaseFatma Alibaz-Oner, Belgin Aldag, Mustafa Aldag, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 22, 2020
Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid LeukemiaHayri Bostan, Tayfur Toptas, Funda Pepedil Tanrikulu, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 24, 2022
Splenectomy in İmmune Thrombocytopenia: A Retrospective Analysis of 25-Year Follow-up Data from a Tertiary Health ClinicSerdar Ozkok, Isik Kaygusuz Atagunduz, Osman Kara, et al.
Current Problems in Cancer|May 15, 2025
Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literatureOzlem Candan, Derya Demirtas, Fatma Temiz, et al.
Nephron. Clinical Practice|September 18, 2010
Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis CMustafa Canbakan, Hakan Senturk, Billur Canbakan, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2017
Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib MesylateIsik Kaygusuz Atagunduz, Tayfur Toptas, Rabia Deniz, et al.
Pageof 6